Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.

about

Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease.

P2860

Q55456183-B61DA839-3E74-404E-860A-9D029F07DD73

P2860

Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.

Item

http://www.wikidata.org/entity/Q38808008

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.

@en

type

Item

label

Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.

@en

prefLabel

Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.

@en

P1476

Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.

@en

P2093

Enara Herran

http://www.w3.org/2001/XMLSchema#string

Jose Luis Pedraz

http://www.w3.org/2001/XMLSchema#string

Oihane Gartziandia

http://www.w3.org/2001/XMLSchema#string

Sara Hernando

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection

Nerve growth factor signaling, neuroprotection, and neural repair.

Treatment interventions for Parkinson's disease: an evidence based assessment

Ciliary neurotrophic factor

Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies

Growth factors in synaptic function.

Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.

Oxidative stress and mitochondrial dysfunction in Alzheimer's disease.

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

P304

1267-1285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM-2016-0019

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rosa Maria Hernandez

Manoli Igartua

P577

2016-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27077453

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.

about

P2860

P2860

Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921